AsCNP/JSNP/JSCNP 2019

Session information

[AsCNP] Oral Session

AsCNP » [AsCNP] Oral Session

[AsCNP_O2] Oral Session 2
Childhood & Adolescent Disorders

Fri. Oct 11, 2019 10:30 AM - 12:10 PM Room 17 (Suehiro)

Chairs: ‌Susan Shur-Fen GAU (National Taiwan University Hospital, Taiwan), Zhong CHEN (Zhejiang University, China)

10:57 AM - 11:06 AM

Shintaro OGAWA1, Kotaro HATTORI1, 2, Daimei SASAYAMA3, Tomoko MIYAKAWA2, Megumi TATSUMI1, 2, Sumiko YOSHIDA4, Hiroshi KUNUGI1 (1. Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan, 2. Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan, 3. Department of Psychiatry, Shinshu University School of Medicine, Nagano, Japan, 4. Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan)

11:15 AM - 11:24 AM

Hiroko KOTAJIMA1, Sakae NARUMI2, Kazuhisa SAKAI3, Tsutomu HASHIKAWA4, Michisuke YUZAKI5, Dai YANAGIHARA6 (1. Addictive Substance Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, 2. Department of Physiology, St. Marianna University School of Medicine, 3. Department of Ultrastructural Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4. Laboratory for Molecular Mechanisms of Thalamus Development, RIKEN Brain Science Institute, 5. Department of Neurophysiology, Keio University school of medicine, 6. Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo)

11:33 AM - 11:42 AM

Tien-Yu CHEN1, 4, Wei-Chung MAO2, Nian-Sheng TZENG1, John WINKELMAN3, Cheryl Ch YANG4, Terry Bj KUO4, Chi-Shin WU5 (1. Department of Psychiatry, Tri-Service General Hospital; School of Medicine, National Defense Medical Center, Taipei, Taiwan, 2. Department of Psychiatry, Cheng Hsin General Hospital, Taipei, Taiwan, 3. Department of Psychiatry and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA, 4. Institute of brain science, National Yang-Ming University, Taipei, Taiwan, 5. Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan)

11:42 AM - 11:51 AM

Kotaro HATTA1, Yasuhiro KISHI2, Ken WADA3, Takashi TAKEUCHI4, Naoko HASHIMOTO5, Kiyoko SUDA6, Toshihiro TAIRA7, Kazuo TSUCHIDA8, Takashi OHMORI5, Nobuya AKIZUKI6, Yuko NISHIO6, Yukiko NAKANISHI6, Chie USUI1, Akiko KURATA9, Naoki HORIKAWA10, Hiroshi EGUCHI10, Shigeo ITO2, Hitoshi MUTO4, Hiroyuki NAKAMURA11, Naohisa UCHIMURA10 (1. Department of Psychiatry, Juntendo University Nerima Hospital, Tokyo, Japan, 2. Department of Psychiatry, Nippon Medical School Musashikosugi Hospital, Kawasaki, Japan, 3. Department of Psychiatry, Hiroshima City Hospital, Hiroshima, Japan, 4. Department of Psychiatry, Tokyo Medical and Dental University, Tokyo, Japan, 5. Department of Psychiatry, Tokushima Prefectural Central Hospital, Tokushima, Japan, 6. Department of Psychooncology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan, 7. Department of Psychiatry, Fukuyama City Hospital, Fukuyama, Japan, 8. Department of Psychiatry, Kurashiki Central Hospital, Kurashiki, Japan, 9. Department of Psychiatry and Neurosciences, Hiroshima University Hospital, Hiroshima, Japan, 10. Department of Psychiatry, Kurume University School of Medicine, Kurume, Japan, 11. Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan)